Company profile for Tabuk Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Tabuk Pharmaceutical Manufacturing Company develops, manufactures, markets, and distributes branded generic pharmaceuticals and under-licensed products in the Middle East, North Africa, and internationally. The company manufactures products in various therapeutic areas, including central nervous system, cardiovascular system, anti-infectives, respiratory system, and muscular skeletal system. It manufactures various dosage form...
Tabuk Pharmaceutical Manufacturing Company develops, manufactures, markets, and distributes branded generic pharmaceuticals and under-licensed products in the Middle East, North Africa, and internationally. The company manufactures products in various therapeutic areas, including central nervous system, cardiovascular system, anti-infectives, respiratory system, and muscular skeletal system. It manufactures various dosage forms, such as oral and injectable cephalosporins, non-ceph, tablets, capsules, sachets, oral syrups and suspensions, nasal sprays, drops, ointments, creams, emulsions, external lotions and solutions, and shampoos.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Saudi Arabia
Address
Address
P.O Box 3844, Tabuk 9222-47532, Al-Madinah Highway Road
Telephone
Telephone
+ 966 4 428 3030
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/tabuk-launches-vibativ-fda-approved-antibiotic-with-life-saving-potential-in-saudi-arabia-302568865.html

PR NEWSWIRE
29 Sep 2025

https://www.prnewswire.com/news-releases/bio-thera-solutions-partners-with-tabuk-pharmaceuticals-to-commercialize-bat2206-a-stelara-ustekinumab-biosimilar-in-saudi-arabia-302338862.html

PRNEWSWIRE
26 Dec 2024

https://www.expresspharma.in/biocon-signs-licensing-agreement-with-tabuk-pharmaceuticals-for-glp-1-products/

EXPRESSPHARMA
27 Sep 2024

https://www.pharmaceutical-technology.com/news/formosa-tabuk-ophthalmic-suspension/

PHARMACEUTICAL TECHNOLOGY
10 May 2024

https://www.prnewswire.com/news-releases/levolta-pharmaceuticals-partners-with-tabuk-pharmaceuticals-for-commercialization-of-investigational-osteoarthritis-therapy-in-middle-east-and-africa-301840528.html

PR NEWSWIRE
01 Jun 2023

https://www.prnewswire.com/news-releases/tabuk-and-cumberland-partner-to-bring-innovative-antibiotic-with-life-saving-potential-to-middle-east-301514843.html

PRNEWSWIRE
31 Mar 2022

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty